BSE · KPL.BO
Kwality Pharmaceuticals Limited
₹3,565.05-₹115.90 (-3.15%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
Loading market information…
BSE · DENISCHEM.BO · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:38 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Denis Chem Lab Limited’s quoted price sits in the lower half of its reported 52-week range, 35.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Denis Chem Lab Limited’s forward annual dividend is ₹2.50 per share, paid annual. The forward yield is 4.1% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Denis Chem Lab Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Denis Chem Lab Limited specializes in the production and distribution of bottled transfusion solutions. Its product offerings include a variety of injectable pharmaceuticals, such as antibiotics, diuretics, parenteral amino acids, and anti-anaerobics, in addition to plasma volume expanders and irrigation solutions. The company, established on July 15, 1980, is headquartered in Jaipur, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹3,565.05-₹115.90 (-3.15%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
₹2,029.00+₹118.85 (+6.22%)
Bharat Parenterals Limited’s quoted price sits in the upper half of its reported 52-week range, 11.48% below the high.
₹767.75-₹0.20 (-0.03%)
Albert David Limited’s quoted price sits in the upper half of its reported 52-week range, 17.61% below the high.
₹414.15+₹13.85 (+3.46%)
BDH Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 32.11% below the high.
₹734.00₹0.00 (0.0%)
Mercury Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 20.95% below the high.
₹63.03-₹2.96 (-4.49%)
Concord Drugs Limited’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
₹30.60-₹3.80 (-11.05%)
ANG Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 38.42% below the high.
₹72.39+₹2.39 (+3.41%)
Colinz Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 17.65% below the high.
